Non-coeliac gluten/wheat sensitivity: advances in knowledge and relevant questions |
| |
Authors: | Umberto Volta Giacomo Caio Tennekoon B. Karunaratne Armin Alaedini Roberto De Giorgio |
| |
Affiliation: | 1. Departments of Medical and Surgical Sciences and Digestive System, Centro di Ricerca Biomedica Applicata (C.R.B.A.), University of Bologna, St. Orsola-Malpighi Hospital, Bologna, Italyumberto.volta@aosp.bo.it;3. Departments of Medical and Surgical Sciences and Digestive System, Centro di Ricerca Biomedica Applicata (C.R.B.A.), University of Bologna, St. Orsola-Malpighi Hospital, Bologna, Italy;4. Mucosal Immunology and Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA;5. Department of Medicine, Columbia University Medical Center, New York, NY, USA;6. Celiac Disease Center, Columbia University Medical Center, New York, NY, USA;7. Institute of Human Nutrition, Columbia University Medical Center, New York, NY, USA |
| |
Abstract: | Introduction: Non-coeliac gluten/wheat sensitivity (NCG/WS) is a syndrome characterized by intestinal and extra-intestinal symptoms occurring a few hours or days after the ingestion of gluten and wheat proteins in patients testing negative for coeliac disease and wheat allergy.Areas covered: The present review deals with recent scientific acquisitions of this gluten-related syndrome, including pathogenetic mechanisms, clinical picture, symptom score, biomarkers and double-blind placebo-controlled trial for diagnosis, and treatment. The methodology used was a literature search on NCG/WS using Medline and Premedline from 1970 to August 2016.Expert commentary: We discussed the pathogenesis of symptom generation and altered gut physiology in NCG/WS. Possible mechanisms include innate and adaptive immune activation, impaired intestinal epithelial barrier and changes in gut microbiome. These interlinked factors may be exploited for their clinical relevance as possible biomarkers. A systemic immune response to microbial and wheat antigens, together with intestinal cell damage, occurs in patients with NCG/WS. Due to the lack of established biomarkers, it is mandatory to validate the diagnosis of the syndrome by means of a well-defined work-up involving dietary challenge. Finally, dietary and other therapeutic indications have been thoroughly reviewed. |
| |
Keywords: | Biomarkers gut microbiome innate immunity adaptive immunity intestinal epithelial barrier non-coeliac gluten sensitivity wheat sensitivity |
|
|